Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4155/fmc-2020-0158 http://scihub22266oqcxt.onion/10.4155/fmc-2020-0158 32638628!7341957!32638628     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Future+Med+Chem 2020 ; 12 (17): 1565-1578 Nephropedia Template TP {{tp|p=32638628|t=2020. Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2 |pdf=|usr=}}{{32638628}} gab.com Text Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2 JO: Future Med Chem http://www.kidney.de/pget.php?&tw=1&pmid=32638628 #FOAvip SARS-CoV-2 has been widely spread around the world and COVID-19 was declared a global pandemic by the WHO. Limited clinically effective antiviral drugs are available now. The development of anti-SARS-CoV-2 drugs has become an urgent work worldwide. At present, potential therapeutic targets and drugs for SARS-CoV-2 are continuously reported, and many repositioning drugs are undergoing extensive clinical research, including remdesivir and chloroquine. On the other hand, structures of many important viral target proteins and host target proteins, including that of RdRp and Mpro were constantly reported, which greatly promoted structure-based drug design. This paper summarizes the current research progress and challenges in the development of anti-SARS-CoV-2 drugs, and proposes novel short-term and long-term drug research strategies. Twit Text FOAVip Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2 ????Future Med Chem http://www.kidney.de/pget.php?&tw=1&pmid=32638628 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32638628 #FOAvip English Wikipedia <ref>{{Cite pmid|32638628}}</ref> Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2 #MMPMID32638628 Fan S; Xiao D; Wang Y; Liu L; Zhou X; Zhong W Future Med Chem 2020[Sep]; 12 (17): 1565-1578 PMID32638628show ga SARS-CoV-2 has been widely spread around the world and COVID-19 was declared a global pandemic by the WHO. Limited clinically effective antiviral drugs are available now. The development of anti-SARS-CoV-2 drugs has become an urgent work worldwide. At present, potential therapeutic targets and drugs for SARS-CoV-2 are continuously reported, and many repositioning drugs are undergoing extensive clinical research, including remdesivir and chloroquine. On the other hand, structures of many important viral target proteins and host target proteins, including that of RdRp and Mpro were constantly reported, which greatly promoted structure-based drug design. This paper summarizes the current research progress and challenges in the development of anti-SARS-CoV-2 drugs, and proposes novel short-term and long-term drug research strategies. |*Drug Repositioning[MESH] |Antiviral Agents/therapeutic use[MESH] |Betacoronavirus/chemistry/drug effects[MESH] |COVID-19[MESH] |Clinical Trials as Topic[MESH] |Coronavirus Infections/*drug therapy[MESH] |Humans[MESH] |Pandemics[MESH] |Pneumonia, Viral/*drug therapy[MESH] |SARS-CoV-2[MESH]Research progress on repositioning drugs and specific therapeutic drug(epmc).pdf DeepDyve Pubget Overpricing